Skip to content
Screener

EyePoint, Inc. EYPT Gross Profit

Discontinued — last reported Q3 '24

Gross Profit at other companies

Merck & Co. logo
Merck & Co.MRK
$12.21B-0.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$9.46M+0.2%
HRO
HarrowHROW
$50.36M+6.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$161.8M+67.8%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Calculated from EyePoint, Inc.’s reported figures.

$10.5Mtotal revenue−$736.0Ktotal cost of revenue=$9.79M

The source filing: EyePoint, Inc.’s 10-Q, filed November 6, 2025. Open the filing →

Filed
Nov 6, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001193125-25-269471

FAQ

What is EyePoint, Inc.'s gross profit?
EyePoint, Inc. (EYPT) reported gross profit of $9.79M in Q3 2024.
How has EyePoint, Inc.'s gross profit changed year-over-year?
EyePoint, Inc.'s gross profit decreased by 30.1% year-over-year, from $14M to $9.79M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about EyePoint, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude